Integer (NYSE:ITGR – Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 5.830-6.400 for the period, compared to the consensus earnings per share estimate of 6.490. The company issued revenue guidance of $1.8 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the stock. Truist Financial lifted their price target on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Friday, February 20th. Raymond James Financial restated an “outperform” rating and issued a $101.00 price target on shares of Integer in a research note on Monday, February 23rd. Wall Street Zen lowered shares of Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Weiss Ratings upgraded shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, February 24th. Finally, Wells Fargo & Company lifted their price target on shares of Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research note on Friday, February 20th. Four research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $96.57.
Read Our Latest Stock Report on Integer
Integer Stock Performance
Integer (NYSE:ITGR – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, topping the consensus estimate of $1.19 by $0.01. The business had revenue of $439.58 million during the quarter, compared to analyst estimates of $426.48 million. Integer had a net margin of 5.55% and a return on equity of 13.26%. The company’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.31 earnings per share. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, equities analysts anticipate that Integer will post 6.47 EPS for the current fiscal year.
Insider Activity at Integer
In other news, VP Tommy P. Thomas sold 825 shares of the company’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $85.00, for a total transaction of $70,125.00. Following the completion of the transaction, the vice president owned 4,381 shares in the company, valued at approximately $372,385. This represents a 15.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.10% of the company’s stock.
Integer News Roundup
Here are the key news stories impacting Integer this week:
- Positive Sentiment: Board launches strategic review to “maximize stockholder value” — a process that can surface sale, merger or other value-creating options and often acts as a near-term catalyst for shares. Integer Announces Strategic Review to Maximize Stockholder Value
- Positive Sentiment: Top-line beat: Q1 sales were ~$440M (up 0.5% y/y) and slightly above analysts’ consensus, showing modest organic growth and supporting near-term revenue momentum. Integer Holdings Corporation Reports First Quarter 2026 Results
- Neutral Sentiment: Q1 EPS came in about in-line (reported $1.20), a hair above some consensus reads and slightly below others — the headline beat was marginal and mixed across data providers. Integer Q1 2026 Earnings Call Transcript
- Neutral Sentiment: Company reiterated its medium‑term target of out‑growing the market by ~200 bps in 2027 and will present at the Bank of America Healthcare Conference (potential for further investor Q&A). Integer to Participate in Bank of America Healthcare Conference on May 12
- Negative Sentiment: FY‑2026 EPS guidance was updated to $5.83–$6.40, below the consensus (~$6.49) — the guidance cut/range under consensus is a clear near-term headwind for valuation. Integer Q1 Release / Guidance
- Negative Sentiment: Some outlets flagged that EPS (“came out at $1.20”) was light versus certain estimates and that the stock initially reacted negatively in some coverage pieces — underscoring mixed investor sentiment despite the strategic review. Integer (ITGR) Q1 Earnings Lag Estimates
- Neutral Sentiment: Trading was briefly halted when the news was released, and volume spiked — this reflects the market digesting both the strategic review and guidance update, increasing short-term volatility. MarketBeat ITGR Snapshot
Hedge Funds Weigh In On Integer
Several institutional investors have recently modified their holdings of ITGR. Kestra Advisory Services LLC lifted its holdings in Integer by 0.6% in the fourth quarter. Kestra Advisory Services LLC now owns 21,424 shares of the medical equipment provider’s stock worth $1,680,000 after purchasing an additional 136 shares during the period. Orion Porfolio Solutions LLC lifted its holdings in Integer by 1.4% in the second quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock worth $1,200,000 after purchasing an additional 138 shares during the period. Lido Advisors LLC lifted its holdings in Integer by 5.5% in the fourth quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock worth $226,000 after purchasing an additional 151 shares during the period. Osaic Holdings Inc. lifted its holdings in Integer by 8.0% in the second quarter. Osaic Holdings Inc. now owns 2,543 shares of the medical equipment provider’s stock worth $312,000 after purchasing an additional 188 shares during the period. Finally, MML Investors Services LLC lifted its holdings in Integer by 2.4% in the second quarter. MML Investors Services LLC now owns 8,222 shares of the medical equipment provider’s stock worth $1,011,000 after purchasing an additional 196 shares during the period. Institutional investors own 99.29% of the company’s stock.
Integer Company Profile
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Read More
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
